Can the prophylactic use of raloxifene, a selective estrogen-receptor modulator, prevent bone mineral loss and fractures in women with diagnosed osteoporosis or vertebral fractures?
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.